PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 7 months ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2025 incluant les dates de publication des résultats et de l'assemblée générale, visant à informer les investisseurs et actionnaires Immunothérapie Événements Financiers Innate Pharma Biotechnologies Calendrier Financier 2025
PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 7 months ago Inside Information / Other news releases Innate Pharma releases its 2025 financial calendar including key publication dates for financial statements and shareholder meetings Financial Statements Investors Financial Calendar 2025 Innate Pharma
BRIEF published on 11/08/2024 at 07:05, 1 year 8 months ago Innate Pharma présente ses innovations en oncologie au SITC 2024 Immunothérapie Innate Pharma NK Cell Engager SITC 2024 Conjugué Anticorps-médicament
BRIEF published on 11/08/2024 at 07:05, 1 year 8 months ago Innate Pharma presents its innovations in oncology at SITC 2024 Immunotherapy Innate Pharma SITC 2024 NK Cell Engage Antibody-drug Conjugate
PRESS RELEASE published on 11/08/2024 at 07:00, 1 year 8 months ago Informations privilégiées / Autres communiqués Annonce de Innate Pharma sur les présentations de données de son portefeuille innovant en oncologie sélectionnées pour le congrès annuel du SITC 2024 Immunothérapie Oncologie ADC Innate Pharma SITC 2024
PRESS RELEASE published on 11/08/2024 at 07:00, 1 year 8 months ago Inside Information / Other news releases Innate Pharma announces new preclinical data on IPH6501 and IPH4502 to be presented at SITC Annual Meeting 2024. Advances in immunotherapy reflected in drug development progress Drug Development Preclinical Data Immunotherapy Innate Pharma SITC Annual Meeting 2024
PRESS RELEASE published on 09/12/2024 at 13:09, 1 year 10 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
BRIEF published on 06/17/2024 at 07:05, 2 years ago Innate Pharma dévoile des résultats prometteurs pour le SAR443579/IPH6101 dans des cancers du sang Sanofi Innate Pharma SAR443579 Leucémie Cancer Du Sang
BRIEF published on 06/17/2024 at 07:05, 2 years ago Innate Pharma reveals promising results for SAR443579/IPH6101 in blood cancers Sanofi Innate Pharma SAR443579 Leukemia Blood Cancer
PRESS RELEASE published on 06/17/2024 at 07:00, 2 years ago Informations privilégiées / Autres communiqués Innate Pharma présente de nouveaux résultats sur l'essai de phase 1/2 mené par Sanofi évaluant le NK Cell Engager SAR443579/IPH6101 dans divers cancers du sang lors du congrès annuel de l'EHA 2024 Étude De Phase 1/2 Innate Pharma NK Cell Engager SAR443579/IPH6101 Cancers Du Sang
Published on 07/14/2026 at 01:45, 5 hours 32 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 7 hours 16 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 8 hours 7 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 9 hours 42 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 11 hours 17 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 07:00, 17 minutes ago The Swiss are confident about the future despite acknowledging some areas of concern
Published on 07/14/2026 at 07:00, 17 minutes ago Malgré quelques inquiétudes, la Suisse envisage l’avenir avec confiance
Published on 07/14/2026 at 06:30, 47 minutes ago Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars
Published on 07/14/2026 at 04:45, 2 hours 32 minutes ago Asia’s Debut of LEAP East in HKCEC Marks Hong Kong’s Largest Inaugural Tech Summit
Published on 07/13/2026 at 18:00, 13 hours 17 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 13 hours 17 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 13 hours 17 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
